(1->4)-beta-D-glucan multiple interactions ISO RGD:1552812 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPLD1 mRNA CTD PMID:36331819 17alpha-ethynylestradiol affects expression ISO RGD:1552812 6480464 Ethinyl Estradiol affects the expression of GPLD1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of GPLD1 mRNA CTD PMID:12082028 17alpha-ethynylestradiol multiple interactions ISO RGD:1552812 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GPLD1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1552812 6480464 Ethinyl Estradiol results in decreased expression of GPLD1 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31826744 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552812 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GPLD1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552812 6480464 Tetrachlorodibenzodioxin affects the expression of GPLD1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPLD1 mRNA CTD PMID:21215274 2,4,6-tribromophenol decreases expression ISO RGD:1606585 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GPLD1 mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of GPLD1 mRNA CTD PMID:12082028 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of GPLD1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1606585 6480464 Lactic Acid results in decreased expression of GPLD1 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1606585 6480464 tetrabromobisphenol A results in increased expression of GPLD1 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1552812 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of GPLD1 promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1552812 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of GPLD1 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1552812 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GPLD1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol affects methylation ISO RGD:1552812 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of GPLD1 gene CTD PMID:31683443 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of GPLD1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of GPLD1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GPLD1 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:1606585 6480464 Aflatoxin B1 results in decreased expression of GPLD1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of GPLD1 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:1606585 6480464 Aflatoxin B1 results in increased methylation of GPLD1 intron CTD PMID:30157460 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of GPLD1 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GPLD1 mRNA CTD PMID:16483693 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of GPLD1 mRNA CTD PMID:19483382 benzo[a]pyrene decreases methylation ISO RGD:1552812 6480464 Benzo(a)pyrene results in decreased methylation of GPLD1 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1606585 6480464 Benzo(a)pyrene affects the methylation of GPLD1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1606585 6480464 Benzo(a)pyrene results in increased methylation of GPLD1 3' UTR CTD PMID:27901495 benzo[e]pyrene increases methylation ISO RGD:1606585 6480464 benzo(e)pyrene results in increased methylation of GPLD1 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPLD1 mRNA CTD PMID:25181051 , PMID:32145629 bisphenol A decreases expression ISO RGD:1606585 6480464 bisphenol A results in decreased expression of GPLD1 protein CTD PMID:31675489 bisphenol A increases expression ISO RGD:1552812 6480464 bisphenol A results in increased expression of GPLD1 mRNA CTD PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GPLD1 gene CTD PMID:28505145 butanal decreases expression ISO RGD:1606585 6480464 butyraldehyde results in decreased expression of GPLD1 mRNA CTD PMID:26079696 calcitriol multiple interactions ISO RGD:1606585 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GPLD1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1606585 6480464 Calcitriol results in increased expression of GPLD1 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1606585 6480464 Carbamazepine affects the expression of GPLD1 mRNA CTD PMID:24752500 cerium trichloride increases expression ISO RGD:1552812 6480464 cerous chloride results in increased expression of GPLD1 mRNA CTD PMID:23573234 CGP 52608 multiple interactions ISO RGD:1606585 6480464 CGP 52608 promotes the reaction [RORA protein binds to GPLD1 gene] CTD PMID:28238834 ciguatoxin CTX1B affects expression ISO RGD:1552812 6480464 Ciguatoxins affects the expression of GPLD1 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1552812 6480464 Cisplatin results in increased expression of GPLD1 protein CTD PMID:31493026 clofibrate multiple interactions ISO RGD:1552812 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GPLD1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GPLD1 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:1552812 6480464 Clofibrate results in decreased expression of GPLD1 mRNA CTD PMID:17585979 , PMID:23811191 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of GPLD1 mRNA CTD PMID:19483382 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GPLD1 mRNA CTD PMID:26577399 decabromodiphenyl ether increases expression ISO RGD:1606585 6480464 decabromobiphenyl ether results in increased expression of GPLD1 protein CTD PMID:31675489 diclofenac affects expression ISO RGD:1606585 6480464 Diclofenac affects the expression of GPLD1 mRNA CTD PMID:24752500 dorsomorphin multiple interactions ISO RGD:1606585 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPLD1 mRNA CTD PMID:27188386 ellagic acid decreases expression ISO RGD:1606585 6480464 Ellagic Acid results in decreased expression of GPLD1 mRNA CTD PMID:12002526 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GPLD1 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:1552812 6480464 Ethanol affects the expression of and affects the splicing of GPLD1 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1552812 6480464 Ethanol results in increased expression of GPLD1 mRNA CTD PMID:30319688 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of GPLD1 mRNA CTD PMID:23962444 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GPLD1 mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:1552812 6480464 Folic Acid results in increased expression of GPLD1 mRNA CTD PMID:25629700 fructose increases expression ISO RGD:1552812 6480464 Fructose results in increased expression of GPLD1 protein CTD PMID:16219662 furan increases methylation EXP 6480464 furan results in increased methylation of GPLD1 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of GPLD1 mRNA CTD PMID:25539665 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of GPLD1 mRNA CTD PMID:24136188 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of GPLD1 mRNA CTD PMID:19483382 leflunomide decreases expression ISO RGD:1606585 6480464 leflunomide results in decreased expression of GPLD1 mRNA CTD PMID:28988120 methapyrilene increases methylation ISO RGD:1606585 6480464 Methapyrilene results in increased methylation of GPLD1 intron CTD PMID:30157460 methylmercury chloride decreases expression ISO RGD:1606585 6480464 methylmercuric chloride results in decreased expression of GPLD1 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1552812 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of GPLD1 mRNA CTD PMID:22401849 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GPLD1 mRNA CTD PMID:28801915 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of GPLD1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GPLD1 mRNA CTD PMID:28943392 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of GPLD1 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1606585 6480464 Nickel results in decreased expression of GPLD1 mRNA CTD PMID:24768652 , PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of GPLD1 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of GPLD1 mRNA CTD PMID:19483382 paracetamol multiple interactions ISO RGD:1552812 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GPLD1 mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPLD1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1552812 6480464 Acetaminophen results in decreased expression of GPLD1 mRNA CTD PMID:29246445 paracetamol affects expression ISO RGD:1552812 6480464 Acetaminophen affects the expression of GPLD1 mRNA CTD PMID:17562736 pentanal decreases expression ISO RGD:1606585 6480464 pentanal results in decreased expression of GPLD1 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552812 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPLD1 mRNA CTD PMID:36331819 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GPLD1 mRNA CTD PMID:12082028 pirinixic acid multiple interactions ISO RGD:1552812 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of GPLD1 mRNA, PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GPLD1 mRNA] CTD PMID:20059764 , PMID:20813756 pirinixic acid decreases expression ISO RGD:1552812 6480464 pirinixic acid results in decreased expression of GPLD1 mRNA CTD PMID:20059764 more ... pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of GPLD1 mRNA CTD PMID:19483382 rac-lactic acid decreases expression ISO RGD:1606585 6480464 Lactic Acid results in decreased expression of GPLD1 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:1606585 6480464 resveratrol results in decreased expression of GPLD1 mRNA CTD PMID:12002526 rimonabant decreases expression ISO RGD:1552812 6480464 Rimonabant results in decreased expression of GPLD1 mRNA CTD PMID:20110567 SB 431542 multiple interactions ISO RGD:1606585 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPLD1 mRNA CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1606585 6480464 sodium arsenite results in decreased expression of GPLD1 mRNA CTD PMID:29301061 sodium fluoride increases expression ISO RGD:1552812 6480464 Sodium Fluoride results in increased expression of GPLD1 protein CTD PMID:28918527 Soman decreases expression EXP 6480464 Soman results in decreased expression of GPLD1 mRNA CTD PMID:19281266 sulforaphane decreases expression ISO RGD:1606585 6480464 sulforaphane results in decreased expression of GPLD1 mRNA CTD PMID:31838189 tamoxifen affects expression ISO RGD:1552812 6480464 Tamoxifen affects the expression of GPLD1 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1606585 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GPLD1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1606585 6480464 Testosterone results in decreased expression of GPLD1 mRNA CTD PMID:21592394 tetrachloromethane decreases expression ISO RGD:1552812 6480464 Carbon Tetrachloride results in decreased expression of GPLD1 mRNA CTD PMID:31919559 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of GPLD1 mRNA CTD PMID:19483382 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GPLD1 mRNA CTD PMID:28943392 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GPLD1 mRNA CTD PMID:23411599 , PMID:34492290 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1606585 6480464 tris(2-butoxyethyl) phosphate affects the expression of GPLD1 mRNA CTD PMID:29024780 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of GPLD1 mRNA CTD PMID:24136188 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of GPLD1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:1606585 6480464 Valproic Acid results in decreased expression of GPLD1 mRNA CTD PMID:24383497 valproic acid multiple interactions ISO RGD:1606585 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPLD1 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1606585 6480464 Valproic Acid affects the expression of GPLD1 mRNA CTD PMID:25979313 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GPLD1 mRNA CTD PMID:16140947 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of GPLD1 mRNA] CTD PMID:16140947 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of GPLD1 mRNA] CTD PMID:16140947 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GPLD1 mRNA CTD PMID:16140947